Journals / Turkish Journal of Urology / 2019 / Cilt: 45 - Sayı: 1

Outcomes of patients with Fournier’s Gangrene: 12-year experience from a tertiary care referral center

Pages
111–116
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The management comprises of a multidisciplinary approach, including parenteral antibiotics, urgent surgical debridement, and comorbidities optimization.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To highlight changing trends of the clinical spectrum, and compare the management optionsand predictors of Fournier’s gangrene (FG) outcomes in a tertiary care referral center.Material and methods: This study included patients with FG between August 2005 and July 2017.
📊
Key Findings & Data:Patients were classified as “responders” and “nonresponders.” We compared the baseline characteristics,clinical spectrum, biochemical data, management modalities, outcomes, and FG severity index (FGSI)and age-adjusted Charlson Comorbidity Index (ACCI) between responders and nonresponders.Results: We studied 72 patients and further divided them to responders (60 patients) and non-responders(12 patients).
💡
Conclusion & Impact:The management comprises of a multidisciplinary approach, including parenteral antibiotics, urgent surgical debridement, and comorbidities optimization.
🔬Design:Modeling & Simulation
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: To highlight changing trends of the clinical spectrum, and compare the management optionsand predictors of Fournier’s gangrene (FG) outcomes in a tertiary care referral center.Material and methods: This study included patients with FG between August 2005 and July 2017. Patients were classified as “responders” and “nonresponders.” We compared the baseline characteristics,clinical spectrum, biochemical data, management modalities, outcomes, and FG severity index (FGSI)and age-adjusted Charlson Comorbidity Index (ACCI) between responders and nonresponders.Results: We studied 72 patients and further divided them to responders (60 patients) and non-responders(12 patients). All were males; the mean age was 56.27+19.27 years (range, 47–85 years). The most common complaints were perineal discomfort (n=62; 86.1%) and fever (n=48; 66.7%). FG originated from thepenoscrotal region in 64 patients (88.8%) and perineal region in 8 patients. Diabetes mellitus was the mostcommon comorbidity (36%). The mean duration of the presentation was 10.19 days (range, 7–30 days).Sixteen patients underwent split skin grafting. The mortality rate was 8.3%. Nonresponders had distinctfindings relative to responders: advanced age (71.5±7.17 vs. 53.23±19.85 years; p=0.00); high blood sugar(245.83±116.26 vs. 139.06±35.64 mg/dL; p<0.01); leukocytosis (27166.67±10295.75 vs. 10558.4±3130.64cumm; p<0.01); elevated serum creatinine (3.78±1.43 vs. 1.38±1.00; p<0.01); hyponatremia (127.33±11.84vs. 137.33±3.42 meq/l; p<0.01), elevated international normalized ratios (1.66±0.28 vs. 1.32±0.07;p<0.01); and high FGSI (9.83±1.11 vs. 6.46±1.68;p<0.01) and ACCI scores (6.33±0.49 vs. 5±0.82; p<0.01).On univariate and multivariate regression analysis, raised blood sugar and deranged international normalized ratios at presentation were significantly associated with decreased response to treatment (p<0.05).Conclusion: An advanced age, diabetes mellitus, renal impairment, leukocytosis, altered sensorium, shock atpresentation, deranged international normalized ratios, and high FGSI and ACCI scores can be used as predictors for poor response. FG risk scores adequately characterize the severity and prognosis of FG, but clinician’sjudgement is vital. The management comprises of a multidisciplinary approach, including parenteral antibiotics, urgent surgical debridement, and comorbidities optimization.

🔖

Cite This Article

Garg, G., SINGH, V., SINHA, R. J., SHARMA, A., PANDEY, S., AGGARWAL, A. (2019). Outcomes of patients with Fournier’s Gangrene: 12-year experience from a tertiary care referral center. Turkish Journal of Urology, Cilt: 45 - Sayı: 1, 111–116. https://ajindex.com/articles/379830

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Smith GL, Bunker CB, Dinneen MD. Fournier's gangrene. Br J Urol 1998;81:347-55. [CrossRef] 2. Nathan B. Fournier's gangrene: a historical vignette. Can J Surg 1998;41:72. 3. Morpurgo E, Galandiuk S. Fournier's gangrene. Surg Clin North Am 2002;82:1213-24. [CrossRef] 4. Clayton MD, Fowler JE Jr, Sharifi R, Pearl RK. Causes, presentation and survival of fifty-seven patients with necrotizing fasciitis of the male genitalia. Surg Gynecol Obstet 1990;170:49-55. 5. Eke N. Fournier's gangrene: a review of 1726 cases. Br J Surg 2000;87:718-28. [CrossRef] 6. Yaghan RJ, Al-Jaberi TM, Bani-Hani I. Fournier's gangrene: changing face of the disease. Dis Colon Rectum 2000;43:1300-8. [CrossRef] 7. Rotstein OD, Pruett TL, Simmons RL. Mechanisms of microbial synergy in polymicrobial surgical infections. Rev Infect Dis 1985;7:151-70. [CrossRef] 8. Johnin K, Nakatoh M, Kadowaki T, Kushima M, Koizumi S, Okada Y. Fournier's gangrene caused by Candida species as the primary organism. Urology 2000;56:153. [CrossRef] 9. Jeong HJ, Park SC, Seo IY, Rim JS. Prognostic factors in Fournier gangrene. Int J Urol 2005;12:1041-4. [CrossRef] 10. Stephens BJ, Lathrop JC, Rice WT, Gruenberg JC. Fournier's gangrene: historic (1764-1978) versus contemporary (1979- 1988) differences in etiology and clinical importance. Am Surg 1993;59:149-54. 11. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83. [CrossRef] 12. Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI. Outcome prediction in patients with Fournier's gangrene. J Urol 1995;154:89- 92. [CrossRef] 13. Mallikarjuna MN, Vijayakumar A, Patil VS, Shivswamy BS. Fournier's Gangrene: Current Practices. ISRN Surg 2012;2012:942437. [CrossRef] 14. Ruiz-Tovar J, Cordoba L, Devesa JM. Prognostic factors in Fournier gangrene. Asian J Surg 2012;35:37-41. [CrossRef] 15. Sorensen MD, Krieger JN, Rivara FP, Broghammer JA, Klein MB, Mack CD, et al. Fournier's Gangrene: population based epidemiology and outcomes. J Urol 2009;181:2120-6. [CrossRef] 16. Kara E, Müezzinoğlu T, Temeltas G, Dinçer L, Kaya Y, Sakarya A, et al. Evaluation of risk factors and severity of a life threatening surgical emergency: Fournier's gangrene (a report of 15 cases). Acta Chir Belg 2009;109:191-7. [CrossRef] 17. Nisbet AA, Thompson IM. Impact of diabetes mellitus on the presentation and outcomes of Fournier's gangrene. Urology 2002;60:775-9. [CrossRef] 1